Halozyme court order blocks Merck Keytruda in eight European markets
A Dutch patent court ruled for Halozyme, ordering Merck to halt manufacture and sale of injectable Keytruda in eight European markets.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.